Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.

Autor: Yogelzang, N J, Herndon, J E 2nd, Cirrincione, C, Harmon, D C, Antman, K H, Corson, J M, Suzuki, Y, Citron, M L, Green, M R
Zdroj: Cancer (0008543X); Jun1997, Vol. 79 Issue 11, p2237-2242, 6p
Databáze: Complementary Index
Externí odkaz: